Pulmonary and Critical Care Medicine 2021

CME : 50.75
Start Date :  Apr 25, 2021End Date :  Apr 29, 2021

Organized by :   Harvard Medical School (HMS)

Specialties :   Pulmonary Medicine, Pulmonary Sciences and Critical Care, Emergency Medicine, Infectious Disease, Hospital Medicine, Internal Medicine, Family Medicine

Fees Fee :   Starting From USD 1,195

Conference Summary

Pulmonary and Critical Care Medicine 2021 is organized by Harvard Medical School (HMS) and will be held from Apr 25 - 29, 2021.

Accreditation:
The Harvard Medical School is accredited by the Accreditation Council for Continuing Medical Education (ACCME) to provide continuing medical education for physicians.

The Harvard Medical School designates this live activity for a maximum of 50.75 AMA PRA Category 1 Credits™. Physicians should claim only the credit commensurate with the extent of their participation in the activity.

Description:
Comprehensive Updates for State-of-the-Art Evaluation, Diagnosis, and Treatment

Pulmonary and Critical Care Medicine will be held online this year, using live streaming, electronic Q&A, and other remote learning technologies.

Overview:
This comprehensive course provides education and updates to optimize your care of patients with:
• Chronic cough
• COPD
• Asthma
• Lung nodules
• Lung cancer
• Sleep apnea
• GERD
• Sepsis
• ARDS
• COVID-19
• Interstitial lung disease
• Sarcoidosis
• Bronchiectasis
• Cystic fibrosis
• Mycobacterial disease
• Pulmonary hypertension
• Thromboembolism
• Lung transplantation

All sessions are led by master clinicians who deliver information in inspiring and entertaining ways, and provide specific recommendations to incorporate the latest updates into your practice, including:
• Up-to-date evidence for managing COVID-19 and ARDS 
• High-flow oxygen therapy for respiratory failure
• Gut and lung microbiome: emerging implications for lung health
• Evaluating occupational and environmental lung disease
• Incorporating new biologic therapies into your practice
• Prescribing medications for interstitial lung disease
• Pulmonary embolus: the latest treatment strategies
• Expanded therapeutic options for mycobacterial infection
• New practice recommendations for sepsis management
• Guidance to conduct end-of-life discussions
• Lung cancer: new targeted therapies and immunotherapies
• Updates in pulmonary pathology
• New treatment options in cystic fibrosis
• Thoracic ultrasound in critical care
• Handling neurologic and surgical emergencies in the medical ICU
• Endobronchial lung volume reduction
• Robotic bronchoscopy

Participants also get a glimpse into the future of the field with short talks given by world-renowned experts on exciting, cutting-edge topics.

Reasons to Attend in 2021:
Practitioners from around the world attend this course for:
• The most current guidelines for treating sepsis
• Evidence-based treatment of ARDS
• Pulmonology in a pandemic: management of COVID-19
• Updates on vaping-related lung disease
• Best practices to apply the newest asthma and COPD biologics
• Guidance to navigate controversies surrounding therapeutic hypothermia and post-cardiac arrest neurologic prognosis
• New approaches that improve outcomes for patients with unexplained chronic cough
• When and how to utilize high-flow oxygen
• 2021 guidelines for management of lung nodules
• Targeted therapies and immunotherapies for lung cancer
• When to consider lung transplantation
• When and how to use antifibrotics in IPF and other ILDs
• Expert advice on mycobacterial diagnostics and therapy
• New concepts in the use of vasopressors in septic shock
• New drugs and combinations in pulmonary hypertension
• Advanced management strategies for pulmonary embolus
• Advanced techniques in interventional pulmonology

Learning Objectives
Upon completion of this course, participants will be able to:
• Evaluate the pathophysiology of lung disease and critical illness, including key pathologic and radiologic features
• Apply evidence from recent literature to clinical case management
• Apply new clinical practice guidelines to improve patient outcomes
• Utilize diagnostic and therapeutic tools offered by specialists outside of pulmonary and critical care medicine to optimally care for complicated patients
• Review the latest evidence and best clinical practices for the care of patients with COVID-19

Topic
✔Controversies of Pharmacology Prescribing
  Controversies of Pharmacology Prescribing
✔End of life care
  End of life care
✔Prescribing of Controlled Drugs
  Prescribing of Controlled Drugs
Credit Info

  • CME : 50.75
Additional Info

Session Brochure : Download Session Brochure

Session Url : Click here

Speaker (s)
10 Speaker(s)
Contact Us

Toll free Number

1(800) 826-2059

Email

support@eMedEvents.com

Chat Assistant

Live Chat
Recommended